Amgen Inc.
Amgen Inc. (AMGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AMGN · as of Jun 8, 2026
Key Statistics
Explore Amgen Inc. Data
amgn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 38 · Buy rate: 57.9%
The AMGN analyst consensus is Buy, based on ratings from 38 Wall Street analysts over the past 3 months. The average 12-month price target is $353.06, representing +1.00% upside from the current price of $349.58.
Competitors & Peers
amgn competitorsAMGN
BMY
BSX
DHR
GILD
GSKStock Performance
Full HistoryAbout Amgen Inc.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscie…
what is amgen inc. · amgn stock overview · amgen inc. company profile · who is amgen inc. ceo · amgn NASDAQ · amgen inc. headquarters · amgen inc. business segments
About Stock Overview & Key Data
Amgen Inc. (AMGN) is a Healthcare company in the Drug Manufacturers - General industry, listed on NASDAQ since Jun 17, 1983. As of the latest trading session, AMGN stock price is $349.58, with a market capitalization of $188.7B. The stock has returned +20.55% over the past 12 months and +6.80% year-to-date.
According to 38 Wall Street analysts, the consensus rating for Amgen Inc. stock is Buy, with an average 12-month price target of $353.06. In fiscal year 2025, Amgen Inc. reported revenue of $36.7B and net income of $7.7B. For detailed data — including Amgen Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Amgen Inc. (AMGN) stock price is $349.58. The stock is traded on NASDAQ under the ticker symbol AMGN. The 52-week range is $267.83 – $391.29.